Drug intelligence / Profile preview

Xiaoketongbi

Development stage: Preclinical
Lead developer: Guangdong Provincial Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Xiaoketongbi (also referred to as Xiaoketongbi Recipe or Xiaoketongyu Recipe) is a Traditional Chinese Medicine (TCM) formulation developed by the **Guangdong Provincial Hospital of Traditional Chinese Medicine**. It is specifically indicated for the treatment of **diabetic painful peripheral neuropathy (DPPN)**. The recipe is designed to address the TCM patterns of 'Xiaoke' (diabetes) and 'Bi' (obstruction/pain), aiming to alleviate neuropathic pain and improve clinical symptoms in diabetic patients. It has been evaluated in clinical trials (e.g., ChiCTR1800019046) to assess its efficacy and safety compared to conventional treatments or placebos.

Other names: Xiaoketongbi RecipeXiaoketongyu Recipe

Beyond the preview

Go deeper on Xiaoketongbi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaoketongbi.

Explore the full profile